The development of the oral controlled absorption system (OCAS®):: A new improved formulation of tamsulosin

被引：13

作者：

Chapple, CR ^{[1
]}

机构：

[1] Royal Hallamshire Hosp, Dept Urol, Sheffield Teching Hosp, NHS Trust, Sheffield S10 2JF, S Yorkshire, England

来源：

EUROPEAN UROLOGY SUPPLEMENTS | 2005年 / 4卷 / 07期

关键词：

tamsulosin; oral controlled absorption system; pharmacokinetics; modified release formulation; review;

D O I：

10.1016/j.eursup.2005.07.001

中图分类号：

R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];

学科分类号：

1002 ; 100201 ;

摘要：

[No abstract available]

引用

页码：1 / 4

页数：4

共 17 条

[1] Nocturia: the major problem in patients with lower urinary tract symptoms suggestive of benign prostatic obstruction (LUTS/BPO) [J].

Abrams, P .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 3 (06) :8-16

[2] Aua guideline on management of benign prostatic hyperplasia (2003). Chapter 1: Diagnosis and treatment recommendations [J].

JOURNAL OF UROLOGY, 2003, 170 (02) :530-547

[3] Introduction and concluding remarks [J].

Chapple, CR .

EUROPEAN UROLOGY, 1999, 36 :1-6

[4] Night time symptom control with omnic (tamsulosin) oral controlled absorption system (OCAS®) [J].

Chapple, CR .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :14-16

[5] THE PREVALENCE OF PROSTATISM - A POPULATION-BASED SURVEY OF URINARY SYMPTOMS [J].

CHUTE, CG ;

PANSER, LA ;

GIRMAN, CJ ;

OESTERLING, JE ;

GUESS, HA ;

JACOBSEN, SJ ;

LIEBER, MM .

JOURNAL OF UROLOGY, 1993, 150 (01) :85-89

[6] The impact of tamsulosin oral controlled absorption system (OCAS) on nocturia and the quality of sleep: Preliminary results of a pilot study [J].

Djavan, B ;

Milani, S ;

Davies, J ;

Bolodeoku, J .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (02) :61-68

[7] State of the art on the efficacy and tolerability of alpha1-adrenoceptor antagonists in patients with lower urinary tract symptoms suggestive of benign prostatic hyperplasia [J].

Djavan, B ;

Chapple, C ;

Milani, S ;

Marberger, M .

UROLOGY, 2004, 64 (06) :1081-1088

[8]

Farmer R., 2004, European Urology Supplements, V3, P60, DOI 10.1016/S1569-9056(04)90231-X

[9]

GARRAWAY WM, 1993, BRIT J GEN PRACT, V43, P318

[10] The improved cardiovascular safety of omnic (tamsulosin) oral controlled absorption system (OCAS®) [J].

Korstanje, C .

EUROPEAN UROLOGY SUPPLEMENTS, 2005, 4 (07) :10-13

← 1 2 →